OFFICE-CJT
22.12.2020 01:32:09 CET | Business Wire | Press release
Seven international musicians held a live-streaming concert on September 30, 2020, at Absolute Blue in Ikebukuro, Tokyo, featuring progressive jazz music mixed with traditional Japanese sounds.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201221005264/en/
YOUTUBE: https://www.youtube.com/watch?v=BjAHU1IfLh8
The concert was hosted by Creative Jazz Trio with four guest performers. Since 2014, the trio has been actively performing a unique blend of classic and jazz music.
The guest performers included University of Science and Arts of Chiapas (UNICACH) Junior Professor Keiko Kotoku, the youngest soloist winner of second prize in the Universal Marimba Competition 2013 in Belgium. She also won first prize in Duo category in the same competition.
Among other international guest musicians were traditional Japanese Gagaku artists Motonori Miura (hichiriki) and Fumiya Otonashi (shō). They have toured worldwide with Tim Hecker, a world-renowned electronic music artist. They also perform in Hecker’s albums “Konoyo” (2018) and “Anoyo” (2019).
The special unit for the concert was named “CJT+Japonism,” reflecting the artists’ intentions to create music that embodies how Japan is viewed from the world. This concert was actually a rare blessing amid the health crisis, as the performers—usually busy performing around the globe—were confined in Japan due to the outbreak of COVID-19.
The live-streaming featured 9 songs written by Takafumi Kakizaki, composer and drummer of Creative Jazz Trio. The YouTube highlight video includes a full 22-minute performance of “Samsara - Rinnetenshō -”, a song themed on Zen, a school of thoughts on life and death, in which every instrument steals the limelight. Performer interviews are also featured in the video.
The leader of the band, Takafumi Kakizaki, is trained in modern music composition and percussion. He currently creates and performs music across all genres in Tokyo. His activities include performing in Japan tours with WDR Radio Orchestra Cologne Soloclarinetist Andy Miles and Portuguese trumpet player Gileno Santana, playing as an invited guest in France, and organizing master classes in Mexico.
Mixing traditional Japanese music with modern music had been on Takafumi’s mind, triggering him to form “CJT+Japonism” with musicians he had acquainted from past performances.
The group hopes to organize a world tour after the COVID-19 pandemic subsides. Creation of their studio-recorded album is underway. Stay tuned for more news from the group.
WEBSITE: http://cjt.tkdr.net/
View source version on businesswire.com: https://www.businesswire.com/news/home/20201221005264/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
